Jean-Philippe DUC is an experienced leader in the pharmaceutical industry, currently serving as Asset Strategy Leader at AbbVie since March 2024. Prior to this role, Jean-Philippe held the position of Vice-President and Head of Global Hemato-Oncology at Sobi from November 2022 to February 2024, where responsibilities included overseeing commercial development in the hemato-oncology sector. Jean-Philippe's extensive tenure at Amgen spanned nearly two decades, during which positions included Global Products General Manager for Hemato-Oncology, leading a significant portfolio of assets, and managing international partnerships for migraine medications. Jean-Philippe possesses a strong background in nephrology and oncology, having held various roles that involved strategic planning, product management, and team leadership across multiple markets and therapeutic areas. Academic credentials include a Doctor of Pharmacy from Université Victor Segalen Bordeaux 2.